Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):…
By J. Douillard, R. Rosell, M. de Lena, F. Carpagnano, R. Ramlau, J. L. Gonzáles-Larriba, T. Grodzki, J. R. Pereira, A. Le Groumellec, V. Lorusso and 12 more. The Lancet Oncology, 2006
1,524 citations recorded by the source corpus.
Subfields: Cancer Research, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/1f994c00b49651dcd781b4907d207de999d91888
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
Citations in the corpus
- Cancer Nanomedicine: From Targeted Delivery to Combination Therapy (2015, background): “cancer and TCH (Taxol, Carboplatin and Herceptin) for treatment of HER2/neu-positive tumors [65,66].”